Real-time enrollment status for this clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 clinical trial
Current Status
Recruiting
Checked: August 17, 2026 at 7:02 PM UTC
| NCT Number | NCT07441681 |
| Recruiting Status | Recruiting |
| Condition | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 |
| Phase | PHASE3 |
| Target Enrollment | 454 participants |
| Active Locations | 63 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | August 17, 2026 (19 hours ago) |
As of August 17, 2026: Clinical trial NCT07441681 is currently recruiting participants. This phase3 study for clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 is actively seeking new participants at 63 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07441681 is actively recruiting participants as of August 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07441681 was last updated 19 hours ago (August 17, 2026). HelloStudys verifies this status automatically.